| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 07/02/2002 | CA2201714C Method for isolation of highly pure von willebrand factor |
| 07/02/2002 | CA2159083C Recombinant .alpha.-n-acetylgalactosaminidase enzyme and cdna encoding said enzyme |
| 07/02/2002 | CA2082960C An apparatus for preparing a concentrate of coagulation factors, such as fibrinogen, from a blood sample |
| 07/02/2002 | CA2073486C Composition for the prevention of lyme disease and use for |
| 07/02/2002 | CA2049548C Lps-producing bacteria, lpss, and lps-containing medicines and veterinary medicines |
| 06/27/2002 | WO2002050304A2 Oncolytic virus |
| 06/27/2002 | WO2002050263A2 Methods_for treating tissue damage by bone-marrow derived stem cells |
| 06/27/2002 | WO2002050243A2 The use of ecm degrading enzymes for the improvement of cell transplantation |
| 06/27/2002 | WO2002050115A1 Modified tachykinin receptors |
| 06/27/2002 | WO2002049677A1 Lentiviral vector-mediated gene transfer and uses thereof |
| 06/27/2002 | WO2002049657A1 Methods and compositions for reducing or preventing onset of milk fever |
| 06/27/2002 | WO2002049656A1 External skin preparations and process for producing the same |
| 06/27/2002 | WO2002049654A1 Shark meat extract |
| 06/27/2002 | WO2002049625A2 Compounds that affect cd83 expression, pharmaceutical compositions comprising said compounds and methods for identifying said compounds |
| 06/27/2002 | WO2002049501A2 Local regional chemotherapy and radiotherapy using in situ hydrogel |
| 06/27/2002 | WO2002020822A3 Biopanning and rapid analysis of selective interactive ligands (brasil) |
| 06/27/2002 | WO2002015881A3 Use of a porous carrier |
| 06/27/2002 | WO2001097838A3 Adjuvants and processes to induce a specific type of immune response |
| 06/27/2002 | WO2001092473A3 Method for cultivating a cartilage replacement and a biomatrix produced according to this method |
| 06/27/2002 | WO2001073025A3 Anti-angiogenic and anti-tumor properties of vascostatin and other nidogen domains |
| 06/27/2002 | WO2001072994A3 Human urothelial cell specific uroplakin transcriptional regulatory sequences, vectors comprising the same, and methods of use thereof |
| 06/27/2002 | US20020083479 Insertion of nucleotide sequences into genome of germ cells; obtain gonads, incubate with transfection mixture, allow insertion, monitor cells for preferential marker |
| 06/27/2002 | US20020082623 Vitro repair of bone and/or cartilage defects |
| 06/27/2002 | US20020082408 GSK3 polypeptides |
| 06/27/2002 | US20020082231 Utilizing ratC polypeptides to screen for antibacterial compounds |
| 06/27/2002 | US20020082216 Compositions and methods for the therapy, diagnosis and monitoring of breast cancer |
| 06/27/2002 | US20020081959 Method and apparatus for preparing a bone product |
| 06/27/2002 | US20020081732 Electroprocessing in drug delivery and cell encapsulation |
| 06/27/2002 | US20020081726 Microfabrication of membranes for the growth of cells |
| 06/27/2002 | US20020081724 Culture of stem cells; for use in human therapeutics |
| 06/27/2002 | US20020081664 Expression and export of interferon-alpha proteins as Fc fusion proteins |
| 06/27/2002 | US20020081659 Nucleic acids, proteins and antibodies |
| 06/27/2002 | US20020081633 Methods for using 22045, a human cyclic nucleotide phosphodiesterase |
| 06/27/2002 | US20020081324 Method of treating aging skin and wrinkles using a combination of growth factors that is commercially prepared or derived from one's own blood |
| 06/27/2002 | US20020081299 Hair cell disorders |
| 06/27/2002 | US20020081291 Alpha-bungarotoxin molecules and uses thereof |
| 06/27/2002 | US20020081286 NRG-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 06/27/2002 | US20020081284 Manipulation of arterial-venous identity |
| 06/27/2002 | US20020081283 Immortalizing the hepatocytes by transforming the hepatocytes with a DNA construct comprising a removable DNA segment containing oncogene, growing immortalized hepatocytes, removing oncogene from immortalized hepatocytes |
| 06/27/2002 | US20020081282 Genetically engineered cell comprising DNA encoding a transmembrane LAG-3 protein (lymphocyte activting gene) on its surface resulting in the protection from graft rejection by a host's immune system |
| 06/27/2002 | US20020081276 Gene therapy utilizing hematopoietic stem cells, lymphoid progenitor cells and/or myeloid progenitor cells which are genetically modified to provide a gene that is expressed in these cells and their progency after differentiation |
| 06/27/2002 | CA2432797A1 Local regional chemotherapy and radiotherapy using in situ hydrogel |
| 06/27/2002 | CA2432301A1 Lentiviral vector-mediated gene transfer and uses thereof |
| 06/27/2002 | CA2432157A1 The use of ecm degrading enzymes for the improvement of cell transplantation |
| 06/27/2002 | CA2430918A1 Compounds that affect cd83 expression, pharmaceutical compositions comprising said compounds and methods for identifying said compounds |
| 06/27/2002 | CA2423331A1 Shark meat extract |
| 06/26/2002 | EP1216710A1 The regulation of systemic immune responses utilizing cytokines and antigens |
| 06/26/2002 | EP1216706A2 Enteral composition for stimulating the immune system |
| 06/26/2002 | EP1216069A1 Method and cycler for peritoneal dialysis |
| 06/26/2002 | EP1216049A2 Methods for treating muscular dystrophy with bone marrow cells |
| 06/26/2002 | EP1216048A2 Solid lipid formulations comprising an inhibitor of lipases and a fatty acid ester of polyols |
| 06/26/2002 | EP1216024A1 Formulation for menopausal women |
| 06/26/2002 | EP0773785B1 Treatment of cancer using hsv mutant |
| 06/26/2002 | EP0644773B1 Anti-aids immunomodulator complex |
| 06/26/2002 | EP0464147B1 Matrix metalloproteinase inhibitor peptides |
| 06/26/2002 | CN1355846A Method for down-regulating IL5 activity |
| 06/26/2002 | CN1355844A Compounds for immunotherapy and diagnosis of breast cancer and methods for their use |
| 06/26/2002 | CN1355714A LIM Mineralization protein splice variants |
| 06/26/2002 | CN1355712A Use of antibodies against CD2O for treatment of graft versus host disease |
| 06/26/2002 | CN1355704A Method for preparing membrane visicles |
| 06/26/2002 | CN1355049A Analgesic and its preparing process |
| 06/26/2002 | CN1355043A Medicine 'Luolixiao' for treating scrofula |
| 06/26/2002 | CN1355042A Capsule 'Weidekang' for treating gastrosis |
| 06/26/2002 | CN1355036A Ointment for treating ostalgia and its preparing process |
| 06/26/2002 | CN1355035A Conception and childbearing helping band |
| 06/26/2002 | CN1355032A Medical wine 'Luomaitong' |
| 06/26/2002 | CN1355031A Medicine for treating tumor and its preparing process |
| 06/26/2002 | CN1355030A 'Tongyuhuazhi' pill |
| 06/26/2002 | CN1354990A Process for preparing nutritive embryo powder and hydrolyzed pearl powder |
| 06/26/2002 | CN1086587C Chinese medicine for treating dental disease and its preparing process |
| 06/26/2002 | CN1086586C Medicine for treating cardiac and cerebral vascular diseases and its preparation method |
| 06/26/2002 | CN1086585C Medicine for pulmonary diseases and its preparation method |
| 06/26/2002 | CN1086583C Powder and pellet for strengening yang |
| 06/26/2002 | CN1086582C Anal fissure ointment and its preparing process |
| 06/25/2002 | US6410824 Animal model for psoriasis for the prevention and treatment of psoriasis in humans |
| 06/25/2002 | US6410721 Polynucleotide decoys that inhibit MHC-II expression and uses thereof |
| 06/25/2002 | US6410720 Compounds and methods for treatment and diagnosis of mycobacterial infections |
| 06/25/2002 | US6410601 Histochrome and its therapeutic use in acute myocardial infarction and ischemic heart disease |
| 06/25/2002 | US6410507 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use |
| 06/25/2002 | US6410320 Kidney stem cells; for use in treatment of kidney defects |
| 06/25/2002 | US6410319 CD20-specific redirected T cells and their use in cellular immunotherapy of CD20+ malignancies |
| 06/25/2002 | US6410316 Methods for producing a vector producing cell line utilizing a high multiplicity of transduction |
| 06/25/2002 | US6410314 Episomally replicating vector, its preparation and use |
| 06/25/2002 | US6410273 Generating methylated nucleotide sequences; obtain prokaryotc cell, transform with nucleotide sequences and expression vector, culture cells, recover methylated nucleotide sequences |
| 06/25/2002 | US6410218 Plasma-like solution |
| 06/25/2002 | US6410063 Composition and method |
| 06/25/2002 | US6410059 Pharmaceutical composition containing cow urine distillate and an antibiotic |
| 06/25/2002 | US6410058 Methods of use for dietary compositions comprising lactoferrin and colostrum |
| 06/25/2002 | US6410044 Crosslinkable macromers |
| 06/25/2002 | US6410016 Method for administering viable microorganism composition for poultry |
| 06/25/2002 | US6410015 Selecting from bone marrow-derived cells population responsive to transforming growth factor beta-1, using as vehicles for transferring genes encoding therapeutic protein to mammal |
| 06/25/2002 | US6410014 Administering protein-tyrosine kinase chimeras capable of directing cytotoxic t lymphocytes to specifically recognize and lyse target cells |
| 06/25/2002 | US6410011 Treatment of restenosis by gene therapy, comprising the administration of a recombinant adenovirus containing a suicide gene |
| 06/25/2002 | US6410010 Recombinant P53 adenovirus compositions |
| 06/25/2002 | CA2201587C Composition comprising a recombinant virus expressing an antigen and a recombinant virus expressing an immunostimulatory molecule |
| 06/20/2002 | WO2002048358A2 Regulation of human chemokine-like receptor |
| 06/20/2002 | WO2002048318A1 Co-culture of hepatocytes and stellate cells |
| 06/20/2002 | WO2002048167A1 Method for generating immortal dendritic cell lines |
| 06/20/2002 | WO2002048107A1 Antitumoral carbazoles |
| 06/20/2002 | WO2002047731A2 Drug delivery compositions and coated medical devices |